First-line treatment of metastatic castration-resistant prostate cancer: the real-world Italian cohort of the Prostate Cancer Registry.

Luca Galli,Vincenzo Emanuele Chiuri,Giuseppe Di Lorenzo,Salvatore Pisconti,Sabrina Rossetti,Zuzana Sirotova,Andrea Muto, Roberto Petrioli,Michele De Tursi,Andrea Sbrana,Giulio Francolini, Antonio Ardizzoia,Claudio Scavelli, Francesco Satta,Silvia Quadrini,Mario Airoldi,Carmine D'Aniello,Andrea Bonetti, Serafino Conforti,Michele Aieta,Patrizia Beccaglia,Antonio Maestri,Lucia Fratino

Tumori（2023）

引用 1|浏览36

暂无评分

摘要

This investigation provided valuable information on the overall mCRPC treatment pattern and the effectiveness of first-line abiraterone and docetaxel in a population representative of everyday practice.

查看译文

关键词

Abiraterone acetate,docetaxel,metastatic castration-resistant prostate cancer,real-world evidence,treatment

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要